Cellectis Shareholders Approve Key Resolutions
Company Announcements

Cellectis Shareholders Approve Key Resolutions

Cellectis SA (CLLS) has released an update.

At Cellectis SA’s Annual Shareholders Meeting on June 28, 2024, several key resolutions were passed with overwhelming support, including the approval of annual and consolidated financial statements, allocation of financial results, and the renewal of Mr. André Choulika’s board membership. Votes showcased a strong consensus among shareholders, with approvals consistently above 98%, demonstrating solid backing for the company’s proposed actions and governance.

For further insights into CLLS stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Auto-Generated NewsdeskCellectis S.A. Reports Q3 2024 Financial Results and Updates
TipRanks Auto-Generated NewsdeskCellectis SA Advances CAR T-cell Therapy for Solid Tumors
TheFlyCellectis price target lowered to $5 from $7 at Barclays
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App